PlainRecalls
FDA Drug Moderate Class II Terminated

Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDC 50268-061-15], Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478

Reported: March 7, 2018 Initiated: February 9, 2018 #D-0544-2018

Product Description

Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDC 50268-061-15], Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478

Reason for Recall

Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.

Details

Recalling Firm
Apace KY LLC
Units Affected
630 cartons
Distribution
Nationwide
Location
Fountain Run, KY

Frequently Asked Questions

What product was recalled?
Acyclovir Tablets, USP, 400 mg, 50 Tablets (5 x 10) unit dose blisters [NDC 50268-061-11] per carton [NDC 50268-061-15], Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478. Recalled by Apace KY LLC. Units affected: 630 cartons.
Why was this product recalled?
Presence of Foreign Tablet/Capsule; cartons labeled to contain Acyclovir tablets may contain Torsemide tablets in some of the blister cavities.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 7, 2018. Severity: Moderate. Recall number: D-0544-2018.